0.3782

2.35% -0.0098

Molecular Templates Inc (MTEM)

Overview News Price History Financials Discussions Forecast Stock Split

Molecular Templates Inc stock is traded at $0.3782, with a volume of 222.35K. It is down -2.35% in the last 24 hours and down -49.48% over the past month. Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Previous Close:

$0.388

Open:

$0.4

24h Volume:

222.35K

Relative Volume:

0.02

Market Cap:

$2.55M

Revenue:

$52.63M

Net Income/Loss:

$-8.12M

P/E Ratio:

-0.0304

EPS:

-12.45

Net Cash Flow:

$-42.02M

1W Performance:

-37.89%

1M Performance:

-49.48%

6M Performance:

-72.14%

1Y Performance:

-92.14%

1-Day Range:

$0.3766

$0.40

1-Week Range:

$0.3766

$0.62

52-Week Range:

$0.295

$5.37

Molecular Templates Inc Stock (MTEM) Company Profile

Name

Molecular Templates Inc

Sector

Healthcare (1195)

Industry

Biotechnology (683)

Phone

512 896 1555

Address

9301 AMBERGLEN BLVD, AUSTIN, TX

Employee

Twitter

@Moltemp

Next Earnings Date

2024-11-11

Latest SEC Filings

MTEM's Discussions on Twitter

Compare MTEM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MTEM	0.3782	2.55M	52.63M	-8.12M	-42.02M	-12.45
VRTX	446.29	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	739.75	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.43	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.44	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.84	24.49B	3.30B	-501.07M	1.03B	11.54

Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-21-21	Initiated	BofA Securities	Buy
Feb-01-21	Initiated	UBS	Neutral
Sep-08-20	Initiated	Jefferies	Buy
Mar-25-20	Initiated	Stifel	Buy
Feb-27-20	Initiated	Barclays	Overweight
Apr-29-19	Initiated	UBS	Buy
Dec-11-18	Initiated	Oppenheimer	Outperform
Oct-08-18	Initiated	Laidlaw	Buy

View All

Molecular Templates Inc Stock (MTEM) Latest News

Nov 20, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN

Nov 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN

Nov 20, 2024

Nov 19, 2024

BB Biotech AG's Strategic Acquisition in Molecular Templates Inc - GuruFocus.com

Nov 19, 2024

Nov 18, 2024

Bb Biotech sells $845,833 in Molecular Templates shares - Investing.com India

Nov 18, 2024

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register

Nov 18, 2024

Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register

Nov 18, 2024

Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register

Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024

Nov 15, 2024

Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga

Nov 15, 2024

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Nov 15, 2024

Nov 14, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - Investing.com India

Nov 14, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Nov 14, 2024

HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com

Nov 14, 2024

Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com

Nov 14, 2024

U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM

Nov 14, 2024

U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn

Nov 14, 2024

Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals

Nov 14, 2024

Nov 05, 2024

Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com

Nov 05, 2024

Clairity Appoints Jeffrey R. Luber as CEO - citybiz

Nov 05, 2024

Oct 25, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN

Oct 25, 2024

Oct 23, 2024

In-vitro Transcription Templates Market to Witness Robust Growth at 19.53% CAGR by 2031 - WhaTech

Oct 23, 2024

Oct 22, 2024

Bitdeer Technologies Holding Co (NASDAQ: BTDR) Is The Number One Stock Currently Moving. - Stocks Register

Oct 22, 2024

Oct 21, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN

Oct 21, 2024

Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 21, 2024

Oct 20, 2024

Global Leukemia Therapeutics Market Overview And Statistics For 2024-2033 - EIN News

Oct 20, 2024

Oct 18, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN

Oct 18, 2024

Oct 17, 2024

Wall Street-Heavily Traded - WDRB

Oct 17, 2024

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 17, 2024

Oct 16, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Oct 16, 2024

Oct 15, 2024

why Molecular Templates Inc [MTEM] is a Good Choice for Investors After New Price Target of $18.00 - The DBT News

Oct 15, 2024

Closing Bell Recap: Molecular Templates Inc (MTEM) Ends at 0.39, Reflecting a -73.48 Downturn - The Dwinnex

Oct 15, 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India

Oct 15, 2024

Oct 14, 2024

MTEM stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa

Oct 14, 2024

MTEM stock touches 52-week low at $0.31 amid market challenges - Investing.com India

Oct 14, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com

Oct 14, 2024

Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - Benzinga

Oct 14, 2024

A closer look at MTEM’s price-to-free cash flow ratio - US Post News

Oct 14, 2024